StockNews.com Initiates Coverage on Organovo (NASDAQ:ONVO)

StockNews.com initiated coverage on shares of Organovo (NASDAQ:ONVO) in a report released on Sunday. The firm set a “sell” rating on the medical research company’s stock.

Organovo Trading Up 1.7 %

Shares of ONVO stock opened at $1.75 on Friday. The company’s 50-day moving average price is $4.09 and its 200-day moving average price is $4.60. Organovo has a twelve month low of $1.56 and a twelve month high of $21.96. The stock has a market cap of $2.98 million, a price-to-earnings ratio of -2.06 and a beta of 1.13.

Organovo (NASDAQ:ONVO) last announced its earnings results on Wednesday, February 19th. The medical research company reported ($2.28) earnings per share for the quarter, topping the consensus estimate of ($2.52) by $0.24. Organovo had a negative net margin of 10,151.64% and a negative return on equity of 346.26%. The company had revenue of $0.02 million during the quarter, compared to analyst estimates of $0.05 million. As a group, equities research analysts predict that Organovo will post -0.77 EPS for the current year.

About Organovo

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.